These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10386679)

  • 41. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
    Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ
    Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use and in-hospital outcomes of recombinant tissue plasminogen activator in pediatric arterial ischemic stroke patients.
    Nasr DM; Biller J; Rabinstein AA
    Pediatr Neurol; 2014 Nov; 51(5):624-31. PubMed ID: 25194722
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy.
    Grotta JC; Chiu D; Lu M; Patel S; Levine SR; Tilley BC; Brott TG; Haley EC; Lyden PD; Kothari R; Frankel M; Lewandowski CA; Libman R; Kwiatkowski T; Broderick JP; Marler JR; Corrigan J; Huff S; Mitsias P; Talati S; Tanne D
    Stroke; 1999 Aug; 30(8):1528-33. PubMed ID: 10436095
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multimode Computed-Tomography-Guided Thrombolysis under a Prolonged Time Window in Acute Ischemic Stroke Patients with Atrial Fibrillation.
    Yang Y; Sun W; Li D; Li XY; Wang XT; Li SC; Zhao HJ; Zhang JB
    Int Heart J; 2019 Jul; 60(4):822-829. PubMed ID: 31257338
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Posterior circulation stroke is associated with prolonged door-to-needle time.
    Sarraj A; Medrek S; Albright K; Martin-Schild S; Bibars W; Vahidy F; Grotta JC; Savitz SI
    Int J Stroke; 2015 Jul; 10(5):672-8. PubMed ID: 23521891
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quality adjusted life year gains associated with administration of recombinant tissue-type plasminogen activator for treatment of acute ischemic stroke: 1998-2011.
    Lubeck DP; Danese MD; Duryea J; Halperin M; Tayama D; Yu E; Lalla D; Grotta JC
    Int J Stroke; 2016 Feb; 11(2):198-205. PubMed ID: 26783311
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stroke outcomes of Japanese patients with major cerebral artery occlusion in the post-alteplase, pre-MERCI era.
    Endo K; Koga M; Sakai N; Yamagami H; Furui E; Matsumoto Y; Shiokawa Y; Yoshimura S; Okada Y; Nakagawara J; Hyogo T; Hasegawa Y; Nagashima H; Fujinaka T; Hyodo A; Terada T; Toyoda K;
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):805-10. PubMed ID: 22721823
    [TBL] [Abstract][Full Text] [Related]  

  • 48. TRUST-tPA trial: Telemedicine for remote collaboration with urgentists for stroke-tPA treatment.
    Mazighi M; Meseguer E; Labreuche J; Miroux P; Le Gall C; Roy P; Tubach F; Amarenco P
    J Telemed Telecare; 2017 Jan; 23(1):174-180. PubMed ID: 26656722
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke Patients Receiving Thrombectomy: Standard or Low Dose Therapy?
    Lin CH; Liu CH; Wang AY; Wu YM; Chen CC; Tsai YH; Chang TY; Huang KL; Wu HC; Lee TH; Chang YJ; Lin CM; Cheng CK; Chang CH
    Curr Neurovasc Res; 2018; 15(3):204-210. PubMed ID: 30014803
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacist Impact on Ischemic Stroke Care in the Emergency Department.
    Gosser RA; Arndt RF; Schaafsma K; Dang CH
    J Emerg Med; 2016 Jan; 50(1):187-93. PubMed ID: 26412104
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of Rate-Limiting Steps in the Provision of Thrombolytics for Acute Ischemic Stroke.
    Metts EL; Bailey AM; Weant KA; Justice SB
    J Pharm Pract; 2017 Dec; 30(6):606-611. PubMed ID: 27834297
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Virtual TeleStroke support for the emergency department evaluation of acute stroke.
    Schwamm LH; Rosenthal ES; Hirshberg A; Schaefer PW; Little EA; Kvedar JC; Petkovska I; Koroshetz WJ; Levine SR
    Acad Emerg Med; 2004 Nov; 11(11):1193-7. PubMed ID: 15528584
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A pilot study of dual treatment with recombinant tissue plasminogen activator and uric acid in acute ischemic stroke.
    Amaro S; Soy D; Obach V; Cervera A; Planas AM; Chamorro A
    Stroke; 2007 Jul; 38(7):2173-5. PubMed ID: 17525395
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bed rest or mobilization after rt-PA? A case-crossover study of factors influencing clinical decision making in stroke services.
    Ha J; Churilov L; Linden T; Bernhardt J
    Int J Stroke; 2013 Apr; 8(3):172-9. PubMed ID: 22098708
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drill down analysis of door-to-needle time of acute ischemic stroke patients treated with intravenous tissue plasminogen activator.
    Schrock JW; Lum M
    Am J Emerg Med; 2014 Nov; 32(11):1330-3. PubMed ID: 25195044
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Retrospective Study of thrombolysis with 0.6 mg/kg Recombinant Tissue Plasminogen Activator (rt-PA) in Mild Stroke.
    Yang J; Yu F; Liu H; An H; Xiong R; Huang D
    Sci Rep; 2016 Aug; 6():31344. PubMed ID: 27510959
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact of acute kidney injury on in-hospital mortality in acute ischemic stroke patients undergoing intravenous thrombolysis.
    Gadalean F; Simu M; Parv F; Vorovenci R; Tudor R; Schiller A; Timar R; Petrica L; Velciov S; Gluhovschi C; Bob F; Mihaescu A; Timar B; Spasovski G; Ivan V
    PLoS One; 2017; 12(10):e0185589. PubMed ID: 29040276
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma let-7i and miR-15a expression are associated with the effect of recombinant tissue plasminogen activator treatment in acute ischemic stroke patients.
    Xiang W; Tian C; Lin J; Wu X; Pang G; Zhou L; Pan S; Deng Z
    Thromb Res; 2017 Oct; 158():121-125. PubMed ID: 28892656
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Implementation of a clinical pathway based on a computerized physician order entry system for ischemic stroke attenuates off-hour and weekend effects in the ED.
    Yang JM; Park YS; Chung SP; Chung HS; Lee HS; You JS; Lee SH; Park I
    Am J Emerg Med; 2014 Aug; 32(8):884-9. PubMed ID: 24928408
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience.
    National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group
    Ann Emerg Med; 2005 Sep; 46(3):243-52. PubMed ID: 16126134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.